retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation This weight-loss drug hasn't been

Aim for 0.7 to 1.0 grams of protein per pound of body weight daily

Notably, North Carolina removed and subsequently reinstated coverage between August 2024 and January 2025

Actual cost depends on insurance coverage, pharmacy dispensing fees, and the dose youre prescribed

GLP-1 medications typically begin lowering blood glucose within 1-2 weeks of starting treatment, though optimal glycemic control usually requires 12-16 weeks as the dose is gradually increased

Microdose semaglutide is $179 and microdose tirzepatide is $269 for a 28-day supply, with async care-team messaging included rather than billed separately.

Zepbound / Tirzepatide Zepbound is a weekly GIP/GLP-1 medication that may provide strong appetite and metabolic support for selected patients